Publications/Abstracts
- 2010-0374 Early Results of a Phase I/II Trial Of Midostaurin (PKC412) and 5-Azacytidine (5-AZA) For Patients (Pts) With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Paolo Strati, MD, Hagop M. Kantarjian, MD, Aziz Nazha, MD, Gautam Borthakur, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Zeev Estrov, MD, Guillermo Garcia-Manero, MD, Trivikram Rajkhowa, Farhad Ravandi, MD, Menda Durand, MSN, RN, Mark Levis, MD, PhD , and Jorge E. Cortes, MD (2013)
- 2011-0188 A Phase I/II Study Of Cytarabine Or Azacitidine In Combination With Tosedostat In Older Patients With AML Or High-Risk MDS
Courtney D. DiNardo, MD, Hagop Kantarjian, MD, Farhad Ravandi, MD, Marina Konopleva, MD, PhD, Tapan M. Kadia, MD, Gautam Borthakur,MD, Naval G. Daver, MD, Menda Durand, MSN, RN, Silvia Rivera, MS, Alfonso Quintas-Cardama, MD, Guillermo Garcia-Manero, MD, and Jorge E. Cortes, MD (2013)
Poster Presentations:
The ABC’s of Oncology Metrics
Bettina Patterson, MSN, RN, OCN. Mercy Cherian, MSN, RN, OCN, Shalonda Smith, RN, Sobha George, MSN, CEN, RN, Lavinia Zanaj, MHA, RN, Menda Durand, MSN, RN, CCRP (2015-2016)
Metrics That Matter: Quality and Patient Safety
Bettina Patterson, MSN, RN, OCN. Mercy Cherian, MSN, RN, OCN, Shalonda Smith, RN, Sobha George, MSN, CEN, RN, Lavinia Zanaj, MHA, RN, Menda Durand, MSN, RN, CCRP (2015-2016)